Evaluation of interleukin-10 (G-1082A) promoter polymorphism in preeclampsia

Journal of Reproduction and Infertility

Volumn 14, Issue 2, 2013, Pages 62-66

  Sowmya, Sabnavis ^a   Ramaiah, Aruna ^b   Sunitha, Tella ^a   Nallari, Pratibha ^c   Jyothy, Akka ^a   Venkateshwari, Ananthapur ^a  

^a OSMANIA UNIVERSITY   (India)

^b Government Maternity Hospital   (India)

^c OSMANIA UNIVERSITY   (India)

Author keywords

ARMS PCR; Cytokines; Interleukin 10; Polymorphism; Preeclampsia

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANT WOMAN; PROMOTER REGION;

EID: 84878389511     PISSN: 22285482     EISSN: 2251676X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. N Engl J Med. 1996;335(20):1480-5.
2. Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72(1):91-7.
3. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728): 1592-4.
4. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9.
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia:an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1990;180:499-506.
6. Xue H, Lin B, An J, Zhu Y, Huang G. Interleukin- 10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer. 2012;12:102.
7. de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM, Huizinga TW. Frequency of functional interleukin- 10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol. 2002;63(4):281-5.
8. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991; 19(19):5444.
9. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol. 1999;7(2): 127-8.
10. Celik H, Avi B, Alper T. Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. Pregnancy Hypertens Int J Women Cardiovasc Health. 2012;2:39-42.
11. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet. 1999;354(9181):788-9.
12. Orange S, Horvath J, Hennessy A. Preeclampsia is associated with a reduced interleukin-10 production from peripheral blood mononuclear cells. Hypertens Pregnancy. 2003;22(1):1-8.
13. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternalfetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14(7):353-6.
14. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, Oleszczuk J. T helper 1- and T helper 2- type cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;86(2):165-70.
15. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol. 1999;41(5):297-306.
16. Roth I, Fisher SJ. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol. 1999;205(1):194-204.
17. Groux H, Cottrez F. The complex role of interleukin- 10 in autoimmunity. J Autoimmun. 2003;20 (4):281-5.
18. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet. 1997;349(9069):1912-3.
19. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 2005;6(2): 167-70.
20. Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig. 2005;12(6):428-32.
21. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci. 2002;59(3):560-9.
22. Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildirim G, et al. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. J Obstet Gynaecol Res. 2010;36(1):64-71.
23. Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol. 2006;55(2):130-5.
24. Stonek F, Hafner E, Metzenbauer M, Katharina S, Stümpflen I, Schneeberger C, et al. Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin- 10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol. 2008;77 (1):85-90.
25. Kamali-Sarvestani E, Kiany S, Gharesi-Fard B, Robati M. Association study of IL-10 and IFNgamma gene polymorphisms in Iranian women with preeclampsia. J Reprod Immunol. 2006;72(1-2):118-26.
26. Makris A, Xu B, Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta. 2006;27(4-5):445-51.
27. Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011; 56(3):550-9.